Ajinomoto Co., Ltd.

Other

Tadamitsu Kishimoto

Yukio Akiyama

Akira Okano

Toshio Hirano

Hiroshi Matsui

Yoshiyuki Takahara

Hitoshi Sato

Osamu Mori

Yasushi Morinaga

Akihiro Nakatani

Yuji Nakata

Yoichi Ozawa

Hideo Kimura

Toshiyuki Ishibashi

The purpose of the present invention is to extract oil from the soybean material containing soybean germ as a main component, and to utilize it. The present invention relates to a method for producing a soybean material, comprising crudely crushing selected soybeans into a size of less than &#xbd;, and separating and concentrating a soybean germ fraction by means of sieving, sorting with air, separation based on the grain shape and the like, to the soybean germ fraction produced by said method, to oil prepared from the soybean material containing soybean germ as a main component, to oil containing 0.8% by weight or more of sterols' content, and to foods containing said oil.

Soybean embryo fat/oil and process for producing soybean material with high embryo concentration

A purified human B-cell differentiation factor (BCDF) which does not have a natural signal peptide attached to the N-terminal thereof, DNA encoding the BCDF, transformed cells containing such DNA, a process for producing and obtaining the BCDF, and compositions containing the BCDF are disclosed.

Recombinant process of producing non-glycosylated B-cell defferentiation

A purified human B-cell differentiation factor (BCDF) which does not have a natural signal peptide attached to the N-terminal thereof, DNA encoding the BCDF, transformed cells containing such DNA, a process for producing and obtaining the BCDF, compositions containing the BCDF and various therapeutic uses are disclosed.

Use of recombinant B-cell differentiation factor for augmenting antibody

Thrombocytopenia is treated by administering a subject suffering from thrombocytopenia a composition containing human B cell differentiation activity in combination with IL-3.

Method of treating thrombocytopenia using human BCDF in combination with

A composition and a method for supporting bone marrow transplantation are disclosed. The composition comprises a therapeutically acceptable amount of human B cell differentiation factor, or its biological equivalent, optionally in combination with an auxiliary agent selected from IL-1, IL-3, IL-4, IL-5, G-CSF, GM-CSF, and M-CSF. The composition also promotes the proliferation of hematopoietic cells in vitro.

Composition and method for supporting bone marrow transplantation

Thrombocytopenia is treated by administering to a subject a therapeutic amount of human B cell differentiation factor or its biological equivalent.

Growing community of inventors

Kawasaki, Japan

Yukio Akiyama